| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 05/03/2007 | WO2002081649A3 ErbB INTERFACE PEPTIDOMIMETICS AND METHODS OF USE THEREOF |
| 05/03/2007 | US20070100133 Erythropoietic compounds |
| 05/03/2007 | US20070100015 Gels for encapsulation of biological meterials |
| 05/03/2007 | US20070099977 Conjugated psychotropic drugs and uses thereof |
| 05/03/2007 | US20070099932 External preparation for athlete's foot treatment |
| 05/03/2007 | US20070098807 Matrices for drug delivery and methods for making and using the same |
| 05/03/2007 | US20070098775 Novel composition for transdermal and/or transmucosal administration of active compounds that ensures adequate therapeutic levels |
| 05/03/2007 | US20070098765 Method of making and using theaflavin, theaflavin-3-gallate, theaflavin-3'-gallate and theaflavin 3,3'-digallate and mixtures thereof |
| 05/03/2007 | US20070098764 Colon cleansing compositions and methods |
| 05/03/2007 | US20070098763 Soluble Fiber Combinations for Weight Control and Improving Parameters of Cardiovascular Health |
| 05/03/2007 | US20070098762 Immunemodulating oligosaccharides |
| 05/03/2007 | US20070098761 Processed fat composition for preventing/ameliorating lifestyle-related diseases |
| 05/03/2007 | US20070098747 Topical pharmaceutical composition for the treatment of inflammatory dermatoses |
| 05/03/2007 | US20070098741 Vectors derived from antibodies for transferring substances into cells |
| 05/03/2007 | US20070098740 Stabilisation of viral microparticles |
| 05/03/2007 | US20070098736 Injection vehicle for polymer-based formulations |
| 05/03/2007 | US20070098730 using a glycoconjugate comprising a dendrimeric or linear poly-Lysine enabling multiple epitopes to be covalently attached thereto; anticancer or antitumor agents |
| 05/03/2007 | US20070098724 Methods of Treatment Using Vascular Occlusion in Combination with One or More Therapies |
| 05/03/2007 | US20070098713 Nanoparticle delivery systems and methods of use thereof |
| 05/03/2007 | US20070098688 Polymer conjugates of interferon beta-1a and uses |
| 05/03/2007 | US20070098684 Methods of reducing aggregation of IL-1ra |
| 05/03/2007 | US20070098677 Ophthalmic compositions containing galactomannan polymers and borate |
| 05/03/2007 | DE112005000725T5 Verfahren und Zusammensetzungen zur Behandlung von Ionen-Ungleichgewichten Methods and compositions for treatment of ion imbalance |
| 05/03/2007 | CA2627716A1 Selective vpac2 receptor peptide agonists |
| 05/03/2007 | CA2627463A1 Anti mineralocorticoid therapy of infection |
| 05/03/2007 | CA2627271A1 Method of preparing an aqueous pharmaceutical composition comprising hydroxypropyl methylcellulose and pharmaceutical c0mp0siti0ns obtainable thereby |
| 05/03/2007 | CA2626939A1 Agents that bind a target in pulmonary tissue for treating respiratory diseases |
| 05/03/2007 | CA2626579A1 Formulation comprising a drug of low water solubility and method of use thereof |
| 05/03/2007 | CA2626394A1 Yeast cell wall particle for delivering osteoprotegerin-encoding polynucleotide |
| 05/03/2007 | CA2625856A1 Drug delivery systems |
| 05/03/2007 | CA2625676A1 Stabilized extended release pharmaceutical compositions comprising a beta-adrenoreceptor antagonist |
| 05/03/2007 | CA2616416A1 Trazodone composition for once a day adminisitiation |
| 05/03/2007 | CA2616204A1 Sustained drug release composition |
| 05/02/2007 | EP1780268A2 PSCA: Prostate stem cell antigen and uses thereof |
| 05/02/2007 | EP1779863A1 Use of TGF-Beta and growth factors in the treatment and prevention of diseases of the intestinal mucosa |
| 05/02/2007 | EP1779854A1 Glycyrrhizin-containing suppository compositions for rectal infusion |
| 05/02/2007 | EP1779076A1 A colour compensating system |
| 05/02/2007 | EP1778361A1 Antimicrobial and/or antiviral composition and to methods for preparing and administering same |
| 05/02/2007 | EP1778299A2 Methods for preparing multivalent constructs for therapeutic and diagnostic applications |
| 05/02/2007 | EP1778298A2 Lipoprotein nanoplatforms |
| 05/02/2007 | EP1778292A2 Use of cell-specific conjugates for treatment of inflammatory diseases of the gastrointestinal tract |
| 05/02/2007 | EP1778291A2 Dimensional analysis of saccharide conjugates with gpc & sec-mals |
| 05/02/2007 | EP1778290A1 Use of glycerol dipalmitostearate for improving the bioavailability of protein active ingredients in subcutaneous or intramuscular injectable formulations |
| 05/02/2007 | EP1778289A1 Carrier for enteral administration |
| 05/02/2007 | EP1778288A2 Deuterium depleted water (ddw) used as adjuvant in cancer therapy for cytostatics toxicity reduction |
| 05/02/2007 | EP1778251A2 Nucleoside phosphonate conjugates as anti hiv agents |
| 05/02/2007 | EP1778249A2 Nucleoside phosphonate conjugates as anti hiv agents |
| 05/02/2007 | EP1778226A1 Aerosol formulation for inhalation, containing an anticholinergenic agent |
| 05/02/2007 | EP1778200A1 Nanocoating for improving biocompatibility of medical implants |
| 05/02/2007 | EP1778185A1 Pressurized foaming composition for topical treatment of psoriasis |
| 05/02/2007 | EP1778172A1 Gilsonite derived pharmaceutical delivery compositions and methods : cosmetic and nail applications |
| 05/02/2007 | EP1778169A1 Beta-(1,3)-beta-(1,4)-glucan as carrier for chemical substances |
| 05/02/2007 | EP1658285B1 Compounds, methods and formulations for the oral delivery of a glucagon like peptide (glp)-1 compound or an melanocortin 4 receptor (mc4) agonist peptide |
| 05/02/2007 | EP1494692B1 Topical pharmaceutical compositions comprising proanthocyanidins, glycyrrhetinic acid and telmesteine for the treatment of dermatitis |
| 05/02/2007 | EP1488801B1 Chemical igf-i composition for the treatment and prevention of neurodegenerative diseases |
| 05/02/2007 | EP1418905B1 Therapeutic agent for depletion of an unwanted protein population from plasma |
| 05/02/2007 | EP1343480B1 Induced phase transition method for the production of microparticles containing hydrophobic active agents |
| 05/02/2007 | EP1311248B1 Transdermal therapeutic system for treating restless-legs-syndrome |
| 05/02/2007 | EP1213964B1 Phytochemicals for treatment of mastalgia and endometriosis |
| 05/02/2007 | EP1165097B1 A pharmaceutical composition of complex carbohydrates and their use |
| 05/02/2007 | EP1093469B1 Linear cyclodextrin copolymers |
| 05/02/2007 | EP1077721B1 Prevention and treatment of hypergastrinemia |
| 05/02/2007 | EP1035840A4 Sustained release formulation containing three different types of polymers and tablet formed therefrom |
| 05/02/2007 | EP1032405A4 Antimutagenic compositions for treatment and prevention of photodamage to skin |
| 05/02/2007 | EP0998305B1 Cytolysis of target cells by superantigen conjugates inducing t-cell activation |
| 05/02/2007 | EP0831827B1 Novel formulations for transdermal delivery of pergolide |
| 05/02/2007 | EP0725648B1 Hepatoselective pharmaceutical actives |
| 05/02/2007 | EP0689586B1 Vpr function and activity |
| 05/02/2007 | CN1956998A Method for the purification of albumin conjugates |
| 05/02/2007 | CN1956737A Ophthalmic thickening agent |
| 05/02/2007 | CN1956736A Orally administered pharmaceutical composition |
| 05/02/2007 | CN1956735A Delivery agents for enhancing mucosal absorption of therapeutic agents |
| 05/02/2007 | CN1956734A Multi-vitamin and mineral nutritional supplements |
| 05/02/2007 | CN1956733A Dietary supplement and method of processing same |
| 05/02/2007 | CN1956722A Improved cytotoxic agents comprising new maytansinoids |
| 05/02/2007 | CN1956717A Niacin sustained release composition for oral administration |
| 05/02/2007 | CN1955280A Potency regeneration cell and culturing method thereof |
| 05/02/2007 | CN1955215A Multifunction hydrogen calcium optical film brightening quality guarantee agent and its preparation method |
| 05/02/2007 | CN1954883A Method for stabilizing hemoglobin oxygen carrier sample |
| 05/02/2007 | CN1954823A Medical composite for eye and its preparation method and quality control method |
| 05/02/2007 | CN1954817A Preparation method of injection type pH and glucose sensitive hydrogel |
| 05/02/2007 | CN1313441C Cyanophenoxy carboxylic acid compounds and compositions for delivering active agents |
| 05/02/2007 | CN1313439C Compounds and compositions for delivering active agents |
| 05/02/2007 | CN1313158C Method of promoting nucleic acid transfer |
| 05/02/2007 | CN1313157C Chitose composition for promoting medicine transfer through skin penetration and its use method |
| 05/02/2007 | CN1313156C Sodium alginate microglobule blood vessel suppositery containing gynecoiatry medicine and its preparation method |
| 05/02/2007 | CN1313155C Topical composition comprising a cyclofructan, a carrier and a drug |
| 05/02/2007 | CN1313154C Medicine composition of adding active component which undissolved in water in carrier composition and its preparing method |
| 05/02/2007 | CN1313152C Vaccines |
| 05/02/2007 | CN1313148C HSA-free formulations of interferon-Beta |
| 05/02/2007 | CN1313092C Sustained-release tablet composition of pramipexole |
| 05/02/2007 | CN1313082C Slow releasing composition and its preparing method |
| 05/02/2007 | CN1313081C Valacycloguanosine tablet containing colloid silica |
| 05/02/2007 | CN1313080C Improved water-insoluble drug particle preparing process |
| 05/01/2007 | US7211662 Soluble highly branched glucose polymers and their method of production |
| 05/01/2007 | US7211659 Polynucleotides encoding antigenic HIV type C polypeptides, polypeptides and uses thereof |
| 05/01/2007 | US7211651 Proteinaceous gels having visualization agents and methods of use thereof |
| 05/01/2007 | US7211596 Stable high-concentration injection containing pyrazolone derivative |
| 05/01/2007 | US7211565 a 15 to 22-residue polypeptide analog that forms an amphipathic alpha helix in the presence of lipids; anticholesterol agents; hypercholesterolemia, cardiovascular disorders, atherosclerosis, restenosis, hypertriglyceridemia, high density lipoprotein deficiency, metabolic disorders |
| 05/01/2007 | US7211445 Conjugation of biomolecules using diels-alder cycloaddition |